Menthol

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as simple backache, arthritis, sprains, strains, and bruises. It is specifically formulated to provide deep penetrating relief for back and muscle pain, particularly for individuals experiencing regular or activity-induced back pain.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage of the product is 7.5% menthol. Healthcare professionals should ensure that the formulation is prepared and administered according to established guidelines.

For topical application, the product should be applied to the affected area as needed, ensuring that the skin is clean and dry prior to application. It is advisable to use a sufficient amount to cover the area adequately without excessive application.

Frequency of application may vary based on the severity of symptoms and individual patient response, but it is generally recommended to apply the product no more than three to four times daily.

Patients should be instructed to wash their hands after application to avoid unintentional contact with sensitive areas, such as the eyes or mucous membranes. If symptoms persist or worsen, patients should be advised to consult a healthcare professional for further evaluation.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to discontinue use and consult a healthcare professional if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Additionally, if excessive skin irritation occurs, it is recommended to stop use and seek medical advice.

Warnings and Precautions

For external use only. This product should not be applied to wounds or damaged skin, nor should it be used in conjunction with a heating pad. Healthcare professionals should advise patients to consult a doctor prior to use if there is any redness present over the affected area.

During application, it is crucial to avoid contact with the eyes and mucous membranes. Additionally, patients should be instructed not to bandage the area tightly to prevent complications.

General precautions include keeping the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be advised to discontinue use and consult a doctor if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve only to recur within a few days. Furthermore, if excessive skin irritation occurs, medical advice should be sought promptly.

In cases of ingestion, it is imperative to obtain emergency medical help or contact a Poison Control Center immediately.

Side Effects

Patients using this product should be aware of several important warnings and precautions. The product is intended for external use only and should not be applied to wounds or damaged skin. Additionally, it should not be used in conjunction with a heating pad.

Before using this product, patients are advised to consult a healthcare professional if they experience redness over the affected area. While using the product, it is crucial to avoid contact with the eyes and mucous membranes, and patients should refrain from tightly bandaging the area of application.

Patients are instructed to discontinue use and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Furthermore, if excessive skin irritation occurs, patients should stop using the product and consult a healthcare provider.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Absorbine Jr Back Patch. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional prior to use. For adolescents and children aged 12 years and older, the recommended application is to the affected area no more than 3 to 4 times daily.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There are no specific statements regarding the use of Absorbine Jr. Back Patch during pregnancy. The available information does not indicate any safety concerns, contraindications, or precautions related to the use of this product in pregnant patients. Additionally, no dosage modifications for pregnant individuals are provided. As such, there are no special precautions outlined for the use of this product during pregnancy. Healthcare professionals should consider the absence of data when advising women of childbearing potential regarding the use of Absorbine Jr. Back Patch.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication.

Should an overdose occur, it is crucial to assess the patient promptly for any symptoms that may arise. Common signs of overdose may include, but are not limited to, severe drowsiness, confusion, respiratory depression, or other neurological manifestations.

Management of an overdose should be initiated immediately. Healthcare providers are advised to monitor the patient's vital signs closely and provide supportive care as necessary. In cases where the specific antidote or treatment protocol is known, it should be administered according to established guidelines.

In the event of an overdose, contacting a poison control center or seeking emergency medical assistance is recommended to ensure appropriate intervention and management.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

Postmarketing experience has identified reports of excessive skin irritation occurring with the use of the product. These events were reported voluntarily or through surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring the safety and well-being of patients and their families.

Storage and Handling

The product is supplied in individual patches, which should be kept in their original pouches until ready for use. It is essential to store the patches at room temperature and to avoid freezing. After use, the patches must be discarded appropriately to ensure safety and compliance with handling guidelines.

Additional Clinical Information

The product is administered topically, with a recommended application frequency of 3 to 4 times daily for adults and children aged 12 years and older. Clinicians should advise patients to consult a doctor prior to use if there is redness over the affected area. While using the product, patients should avoid contact with eyes and mucous membranes and refrain from tight bandaging. If the condition worsens, symptoms persist beyond 7 days, or if symptoms resolve and then recur within a few days, patients are instructed to discontinue use and seek medical advice.

Drug Information (PDF)

This file contains official product information for Absorbine Jr Back Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)